This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) for the provision of COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing equipment, reagents, and consumables. The contract has a ceiling value of $13,600.00 and is a firm fixed-price delivery order with a completion date of March 3, 2025. The contract is not set aside for any specific business designation. Cepheid is the...
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, was issued by the Defense Logistics Agency (DLA) for the supply of diagnostic testing equipment, reagents, and consumables for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract, valued at $27,200.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid holds several significant federal contract Indefinite Delivery...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the delivery of COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic equipment, reagents, test kits, and maintenance services. The $13,600.00 firm fixed-price contract was awarded by the Defense Logistics Agency, an agency within the Department of Defense, and does not have a set-aside designation. The contract is a delivery order under a larger Indefinite Delivery...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) to provide COVID-19, influenza, and respiratory syncytial virus (RSV) testing equipment, reagents, and services. The $15,552.00 firm fixed-price delivery order contract has an ultimate completion date of April 21, 2025. Cepheid, the prime contractor, specializes in advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) for $21,080.00. The contract is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the government with XPCOV2/FLU/RSV-10 diagnostic testing systems, reagents, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus. This award is part of a larger...
This is a federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, for the delivery of COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing products and services. The contract, with a ceiling value of $3,400.00, was awarded by the Defense Logistics Agency's Medical Supply Chain program. It is a firm fixed-price delivery order contract with no set-aside designation. Cepheid has also been awarded other federal contracts and...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the procurement of XPCOV2/FLU/RSV-10 testing products. The contract has a ceiling value of $4,080.00 and an ultimate completion date of January 13, 2025. Cepheid is the prime contractor for this award, which is not associated with a set-aside program. The contract provides the DLA with rapid, precise...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a defense agency. The $6,800.00 firm fixed-price delivery order contract is for the provision of XPCOV2/FLU/RSV-10 testing products, which are used to detect COVID-19, influenza, and respiratory syncytial virus. The contract has an ultimate completion date of April 4, 2025. Cepheid is an original equipment manufacturer and prime contractor in the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, worth $13,600.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This award is part of...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $1,054.20, is a firm fixed-price delivery order contract with no set-aside designation. The contract requires Cepheid to provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions are used to detect a...